English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Transcatheter aortic valve implantation (TAVI) is an established treatment option for symptomatic severe aortic stenosis in high [1] and intermediate risk patients [2]. With a prevalence of 1% to 2% in countries outside China, bicuspid aortic valve (BAV) disease is a common congenital malformation [3] that often results in premature aortic stenosis. Since BAV represents a challenge for interventional treatment [4], it traditionally has been considered as a relative contraindication against TAVI. The Lotus valve (Boston Scientific Corp, Marlborough MA) is a mechanically expandable, fully repositionable and retrievable second-generation TAVI prosthesis with an outer adaptive seal that facilitates accurate positioning, early valve function, and hemodynamic stability during deployment, and minimizes paravalvular leakage [5]. Therefore, it might be a good treatment option for BAV stenosis. For planning TAVI procedures, an in-depth analysis of multidetector computed tomography (MDCT) images is crucial. In most reports of interventional treatment of BAV stenosis, preprocedural measurements were done according to current guidelines [6]. However, such measurements might lead to inaccurate annular sizing and prosthesis selection in BAV disease. Specifically, measurement of the basal ring may lead to the selection of too large prostheses, potentially leading to suboptimal results, or may make the intervention impossible due to non-availability of the necessary large valve sizes.

Supra-annular sizing for transcatheter valve implantation in bicuspid aortic stenosis